# Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine

> **NCT04910841** · NA · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 55 (estimated)

## Conditions studied

- Hyperglycemia
- Hypotension
- Shock, Septic

## Interventions

- **DEVICE:** CGM GUARDIAN 2

## Key facts

- **NCT ID:** NCT04910841
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-11
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04910841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04910841, "Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04910841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*